Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
Clinical trial NCT06686524 · RECRUITING
Trial details
- NCT number
- NCT06686524
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2026-11-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.